一个双重的计算和实验策略来增强TSLP抗体亲和力,以改善喘治疗
Yitong Lv1, He Gong1, Xuechao Liu2
1College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
PLoS computational biology
|March 27, 2024
概括
研究人员增强了一种针对胸膜 stromal lymphopoietin (TSLP) 的抗体,以改善喘治疗. 计算方法加速了抗体的产生.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 计算生物学 计算生物学
背景情况:
- 胸膜 stromal 淋巴蛋白 (TSLP) 是喘和过敏性疾病发病的一个关键细胞因子.
- 准TSLP信号是一种有前途的喘治疗策略.
- 现有的抗体,如AMG157,显示出潜力,但抗体的发展需要优化.
研究的目的:
- 为了增强T6抗体的结合亲和力,该抗体针对TSLP.
- 利用计算和实验方法来进行抗体亲和力成熟.
- 开发一种更强大的TSLP阻断抗体,用于潜在的治疗应用.
主要方法:
- 氨酸扫描和分子对接被用于识别关键残留物.
- 计算工具 (mCSM-PPI2,GEO-PPI) 预测了关键的氨基酸位点.
- 进行了局部定向突变发生和实验验证,以设计抗体.
主要成果:
- 确定了影响TSLPT6抗体亲和力的关键氨基酸残留物.
- 生成突变T6抗体,显著改善TSLP结合亲和力.
- 工程抗体对TSLP的证明增强阻断能力.
结论:
- 计算机辅助技术加速了抗体亲和力成熟,减少了实验时间和成本.
- 整合计算和实验方法是开发向治疗抗体的有效方法.
- 增强的T6抗体显示出治疗TSLP介导疾病 (如喘) 的潜力.
更多相关视频
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
22.5K
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
7.7K
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
291
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
291
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
288
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
288
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
